Last update 08 May 2025

Azelastine Hydrochloride/Beclometasone Dipropionate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
GR x H1 receptor
Action
agonists, antagonists
Mechanism
GR agonists(Glucocorticoid receptor agonists), H1 receptor antagonists(Histamine H1 receptor antagonists)
Therapeutic Areas
Immune System DiseasesInfectious DiseasesOtorhinolaryngologic Diseases+ [1]
Active Indication-
Inactive Indication
Rhinitis, Allergic, Seasonal
Originator Organization
Pharmactive Ilaç Sanayi ve Tic A.S.
Active Organization-
Inactive Organization
Pharmactive Ilaç Sanayi ve Tic A.S.
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC22H25Cl2N3O
InChIKeyYEJAJYAHJQIWNU-UHFFFAOYSA-N
CAS Registry79307-93-0
View All Structures (2)

Related

1
Clinical Trials associated with Azelastine Hydrochloride/Beclometasone Dipropionate
NCT04817800
/ CompletedPhase 1/2
An Open Label, Randomized, Three-treatment, Three-period, Crossover, Single Dose Study, to Investigate Drug-drug Interaction and Relative Bioavailability Between the Fixed Dose Combination Azelastine Hydrochloride / Beclomethasone Dipropionate (140/100 μg Azelastine Hydrochloride / Beclomethasone Dipropionate) Nasal Spray, and Beclomethasone Dipropionate Nasal Spray (100 μg Beclomethasone Dipropionate) in the Test Vehicle, and the Commercially Available Product, RinoClenil® Nasal Spray (100 μg Beclomethasone Dipropionate), in Healthy Subjects Under Fasting Conditions
100 Clinical Results associated with Azelastine Hydrochloride/Beclometasone Dipropionate
Login to view more data
100 Translational Medicine associated with Azelastine Hydrochloride/Beclometasone Dipropionate
Login to view more data
100 Patents (Medical) associated with Azelastine Hydrochloride/Beclometasone Dipropionate
Login to view more data
100 Deals associated with Azelastine Hydrochloride/Beclometasone Dipropionate
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Rhinitis, Allergic, SeasonalPhase 2-
Pharmactive Ilaç Sanayi ve Tic A.S.
26 Mar 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free